Whitebox Advisors LLC Ibere Pharmaceuticals Transaction History

Whitebox Advisors LLC

$1.66 Billion
Q2 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$9.69 - $9.81 $58,140 - $58,860	-6,000 Reduced 7.38%	75,246 $738,000
Q4 2021 Feb 14, 2022	BUY	$9.68 - $9.77 $60,461 - $61,023	6,246 Added 8.33%	81,246 $790,000
Q2 2021 Aug 16, 2021	BUY	$9.65 - $9.95 $723,750 - $746,250	75,000 New	75,000 $725,000

Others Institutions Holding IBER

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About IBERE PHARMACEUTICALS

Ticker IBER
Exchange NYSE
Sector Financial Services
Industry Shell Companies
Shares Outstandng 13,800,000
Description
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

More about IBER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitebox Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whitebox Advisors LLC with notifications on news.